Skip to content

Construction and application of clinical nursing pathway for diabetic macular edema based on IKAP theory

Construction and application of clinical nursing pathway for diabetic macular edema based on IKAP theory

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071070
Enrollment
Unknown
Registered
2023-05-04
Start date
2023-05-04
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Macular Edema

Interventions

control group:A routine care program for diabetic macular edema was adopted, and the routine care measures included providing patients with disease-related knowledge, medication guidance, dietary guid
experimental group :On the basis of the control group, the clinical care pathway intervention model guided by the IKAP theory was adopted.

Sponsors

The Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for diabetic macular edema in the Clinical Guidelines for the Diagnosis and Treatment of Diabetic Retinopathy in China (2014), and undergo vitreous drug injection for the first time; (2) Age=18 years old; (3) Having the ability to use smart phones independently; (4) Clear awareness and reading ability; (5) Informed consent of the patients and their family members.

Exclusion criteria

Exclusion criteria: (1) Combined with heart, brain, liver, kidney and other serious diseases and malignant tumors; (2) A history of serious mental illness;

Design outcomes

Primary

MeasureTime frame
Patient satisfaction scores for day surgery;

Secondary

MeasureTime frame
Patient health knowledge awareness rate score;Patient's anxiety and depression score;Medical staff satisfaction score;

Countries

CHINA

Contacts

Public ContactYing Han

The Affiliated Hospital of Guizhou Medical University

1349164714@qq.com+86 18984021813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026